Heteromerization of Dopamine D2 and Oxytocin Receptor in Adult Striatal Astrocytes.
astrocyte processes
glutamate
heterodimers
molecular modelling
neuroglia
rat
striatum
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
28 Feb 2023
28 Feb 2023
Historique:
received:
28
12
2022
revised:
22
02
2023
accepted:
23
02
2023
entrez:
11
3
2023
pubmed:
12
3
2023
medline:
15
3
2023
Statut:
epublish
Résumé
The ability of oxytocin (OT) to interact with the dopaminergic system through facilitatory D2-OT receptor (OTR) receptor-receptor interaction in the limbic system is increasingly considered to play roles in social or emotional behavior, and suggested to serve as a potential therapeutic target. Although roles of astrocytes in the modulatory effects of OT and dopamine in the central nervous system are well recognized, the possibility of D2-OTR receptor-receptor interaction in astrocytes has been neglected. In purified astrocyte processes from adult rat striatum, we assessed OTR and dopamine D2 receptor expression by confocal analysis. The effects of activation of these receptors were evaluated in the processes through a neurochemical study of glutamate release evoked by 4-aminopyridine; D2-OTR heteromerization was assessed by co-immunoprecipitation and proximity ligation assay (PLA). The structure of the possible D2-OTR heterodimer was estimated by a bioinformatic approach. We found that both D2 and OTR were expressed on the same astrocyte processes and controlled the release of glutamate, showing a facilitatory receptor-receptor interaction in the D2-OTR heteromers. Biochemical and biophysical evidence confirmed D2-OTR heterodimers on striatal astrocytes. The residues in the transmembrane domains four and five of both receptors are predicted to be mainly involved in the heteromerization. In conclusion, roles for astrocytic D2-OTR in the control of glutamatergic synapse functioning through modulation of astrocytic glutamate release should be taken into consideration when considering interactions between oxytocinergic and dopaminergic systems in striatum.
Identifiants
pubmed: 36902106
pii: ijms24054677
doi: 10.3390/ijms24054677
pmc: PMC10002782
pii:
doi:
Substances chimiques
Dopamine
VTD58H1Z2X
Glutamic Acid
3KX376GY7L
Oxytocin
50-56-6
Receptors, Oxytocin
0
Receptors, Dopamine D2
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : MIUR-Italy
ID : FFABR
Organisme : University of Genova
ID : Ph.D School Department of Experimental Medicine contribution 2021
Organisme : MUR-Italy
ID : RBAP11ETKA-005
Organisme : MUR-Italy
ID : Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN) 20177XJCHX_003
Références
Science. 2013 Oct 18;342(6156):373-7
pubmed: 24136970
J Chem Theory Comput. 2019 Jan 8;15(1):775-786
pubmed: 30525595
Gen Physiol Biophys. 2013 Dec;32(4):517-25
pubmed: 23970035
Curr Opin Pharmacol. 2021 Feb;56:1-6
pubmed: 32862045
Proteins. 2009;77 Suppl 9:114-22
pubmed: 19768677
Front Cell Neurosci. 2021 May 20;15:644126
pubmed: 34093129
Neurochem Int. 2012 Jun;60(8):768-72
pubmed: 22417724
Lancet Neurol. 2022 Jan;21(1):89-102
pubmed: 34942142
Neurobiol Aging. 2015 Apr;36(4):1686-1691
pubmed: 25683516
Physiol Rev. 2018 Jan 1;98(1):239-389
pubmed: 29351512
J Neurosci. 2020 Jul 22;40(30):5757-5768
pubmed: 32541069
CNS Spectr. 2020 Aug;25(4):493-501
pubmed: 31659946
Horm Behav. 2016 Jul;83:23-38
pubmed: 27189764
Front Immunol. 2021 Dec 01;12:794770
pubmed: 34925379
Nature. 2013 Feb 7;494(7435):90-4
pubmed: 23242137
Neuropharmacology. 2021 Nov 1;199:108758
pubmed: 34433089
Front Mol Neurosci. 2022 Dec 08;15:1055344
pubmed: 36618821
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2110746119
pubmed: 35858361
Neuroscience. 2010 Sep 29;170(1):67-77
pubmed: 20620192
Nat Neurosci. 2004 Oct;7(10):1048-54
pubmed: 15452576
Br J Pharmacol. 2018 Feb;175(3):501-516
pubmed: 29156097
Cells. 2020 Dec 07;9(12):
pubmed: 33297340
Methods Mol Biol. 2015;1215:47-71
pubmed: 25330958
Biomolecules. 2021 Aug 25;11(9):
pubmed: 34572487
Neurosci Biobehav Rev. 2017 Jun;77:87-97
pubmed: 28279812
Transl Neurodegener. 2021 Oct 18;10(1):39
pubmed: 34657636
Neuroimage. 2019 Jan 1;184:781-789
pubmed: 30266264
Acta Physiol (Oxf). 2006 May-Jun;187(1-2):329-44
pubmed: 16734770
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
J Neural Transm (Vienna). 2007 Jan;114(1):49-75
pubmed: 17066251
Nat Rev Neurosci. 2018 Nov;19(11):643-654
pubmed: 30301953
Neurobiol Dis. 2022 Jun 15;168:105716
pubmed: 35367629
Stroke. 2015 Sep;46(9):2637-46
pubmed: 26251254
Peptides. 2012 Dec;38(2):312-7
pubmed: 22985856
Int J Mol Sci. 2022 Feb 19;23(4):
pubmed: 35216441
Neural Plast. 2014;2014:232105
pubmed: 24511394
Cell. 2006 May 19;125(4):775-84
pubmed: 16713567
Trends Neurosci. 2015 Sep;38(9):535-49
pubmed: 26316036
Nat Neurosci. 2007 Mar;10(3):331-9
pubmed: 17310248
J Neurosci. 2007 Dec 12;27(50):13822-34
pubmed: 18077694
Brain Res Bull. 2018 Jan;136:17-25
pubmed: 28069435
J Neurochem. 2017 Jan;140(2):268-279
pubmed: 27896809
Int Rev Neurobiol. 2018;140:201-247
pubmed: 30193705
Trends Cogn Sci. 2009 Jan;13(1):27-35
pubmed: 19084465
Brain Res Rev. 2010 May;63(1-2):11-25
pubmed: 20176054
J Neurophysiol. 2005 Mar;93(3):1699-709
pubmed: 15738276
Brain Struct Funct. 2016 Jun;221(5):2427-42
pubmed: 26026482
J Comput Chem. 2005 Dec;26(16):1781-802
pubmed: 16222654
CNS Neurosci Ther. 2010 Jun;16(3):e92-123
pubmed: 20557568
J Mol Neurosci. 2018 Aug;65(4):456-466
pubmed: 30030763
Mol Psychiatry. 2021 Jan;26(1):265-279
pubmed: 32514104
Glia. 1993 Sep;9(1):48-56
pubmed: 7902337
Mol Psychiatry. 2013 Aug;18(8):849-50
pubmed: 22824810
Glia. 2007 Feb;55(3):274-81
pubmed: 17091490
Brain Res Rev. 2010 May;63(1-2):103-12
pubmed: 20097227
Front Synaptic Neurosci. 2018 Jul 10;10:20
pubmed: 30042672
Biol Psychiatry. 2014 Sep 1;76(5):367-76
pubmed: 24120094
Neural Plast. 2018 Jul 2;2018:4864107
pubmed: 30057594
Rev Neurosci. 2018 Jun 27;29(4):377-386
pubmed: 29222936
Brain Res. 1994 Oct 31;662(1-2):11-24
pubmed: 7859063
Sci Rep. 2020 Sep 2;10(1):14474
pubmed: 32879386
J Pharmacol Exp Ther. 2010 Jan;332(1):210-9
pubmed: 19794031
Neurochem Res. 2015 Dec;40(12):2600-14
pubmed: 25894681
J Mol Neurosci. 2005;26(2-3):193-208
pubmed: 16012193
Biol Psychiatry. 2016 Feb 1;79(3):243-50
pubmed: 26049207
J Physiol Sci. 2015 Mar;65(2):171-7
pubmed: 25617267
Nature. 2018 Mar 8;555(7695):269-273
pubmed: 29466326
J Neurochem. 2016 Mar;136(5):1004-16
pubmed: 26576509
Front Neuroendocrinol. 2004 Sep-Dec;25(3-4):150-76
pubmed: 15589267
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
J Neurosci. 2009 Feb 11;29(6):1743-54
pubmed: 19211881
Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12915-9
pubmed: 21753079
Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2208876119
pubmed: 35858458
Science. 2001 May 4;292(5518):923-6
pubmed: 11340204
Nat Neurosci. 2021 Apr;24(4):529-541
pubmed: 33589833
Neuropsychopharmacology. 2021 Oct;46(11):1864-1872
pubmed: 34253855
Neurobiol Dis. 2014 Jan;61:55-71
pubmed: 24076101
Prog Neurobiol. 2022 Oct;217:102328
pubmed: 35870680
Acta Physiol Scand. 1986 Oct;128(2):201-7
pubmed: 3022556
Rev Neurosci. 2015;26(5):489-506
pubmed: 26103627
Biomedicines. 2021 Sep 28;9(10):
pubmed: 34680458
Trends Immunol. 2020 Sep;41(9):758-770
pubmed: 32819810
Front Syst Neurosci. 2011 Aug 23;5:68
pubmed: 21897810
Transl Neurodegener. 2015 Oct 12;4:19
pubmed: 26464797
Neurobiol Dis. 2020 Oct;144:105028
pubmed: 32736085
Biochim Biophys Acta. 2016 Nov;1862(11):2075-2085
pubmed: 27425032
Nucleic Acids Res. 2021 Jul 2;49(W1):W237-W241
pubmed: 34048578
Trends Neurosci. 2017 Jun;40(6):358-370
pubmed: 28527591
Int J Mol Sci. 2019 May 17;20(10):
pubmed: 31109007
Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9
pubmed: 11413487
Front Neuroanat. 2015 Sep 25;9:117
pubmed: 26441550
Br J Pharmacol. 2010 Jun;160(4):785-809
pubmed: 20136842
Int J Mol Sci. 2019 Aug 02;20(15):
pubmed: 31382374
Sci Rep. 2019 Dec 17;9(1):19252
pubmed: 31848444
Transl Psychiatry. 2021 Jul 10;11(1):388
pubmed: 34247185
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2151-5
pubmed: 14766975
Nat Med. 2018 Jul;24(7):931-938
pubmed: 29892066
Pharmacol Rev. 2020 Oct;72(4):829-861
pubmed: 32912963
J Neurosci. 2018 Jan 3;38(1):14-25
pubmed: 29298905
Eur J Neurosci. 2004 Oct;20(8):2235-9
pubmed: 15450103
Neuropsychopharmacology. 2019 Jan;44(2):295-305
pubmed: 30120410
Glia. 2012 Feb;60(2):229-38
pubmed: 22009457
Science. 2015 Aug 14;349(6249):730-4
pubmed: 26273054
J Microsc. 2006 Dec;224(Pt 3):213-32
pubmed: 17210054
Neurobiol Dis. 2022 Jun 15;168:105697
pubmed: 35314319
Pharmacol Res Perspect. 2021 Dec;9(6):e00822
pubmed: 34676988
Nat Rev Drug Discov. 2017 Dec;16(12):829-842
pubmed: 29075003
Nat Rev Neurol. 2020 Jun;16(6):303-318
pubmed: 32332985
Neurology. 1994 Jan;44(1):84-9
pubmed: 7904735
Philos Trans R Soc Lond B Biol Sci. 2022 Aug 29;377(1858):20210047
pubmed: 35858106
J Neurosci. 2015 Oct 14;35(41):13827-35
pubmed: 26468182
Rev Physiol Biochem Pharmacol. 2023;186:95-134
pubmed: 36416982
Neuropharmacology. 2015 Dec;99:396-407
pubmed: 26260232
Biotechniques. 2011 Aug;51(2):111-8
pubmed: 21806555
Neurosci Res. 2023 Feb;187:21-39
pubmed: 36181908
Sci Adv. 2020 Jul 15;6(29):eabb5419
pubmed: 32832646
Annu Rev Neurosci. 1997;20:375-97
pubmed: 9056719
Pharmacol Biochem Behav. 2014 Apr;119:49-60
pubmed: 23850525
Neuroscience. 1993 Dec;57(3):501-35
pubmed: 8309521
Neuromolecular Med. 2016 Mar;18(1):50-68
pubmed: 26530396
Biomedicines. 2021 Jan 07;9(1):
pubmed: 33430188
Br J Pharmacol. 2018 Jul;175(14):2809-2824
pubmed: 28378414
J Alzheimers Dis. 2020;74(3):883-901
pubmed: 32083584
Physiol Rev. 2017 Oct 1;97(4):1431-1468
pubmed: 28904001